A three-drug combination targeting aggressive advanced breast cancer could potentially double the amount of time patients ...

A new drug combination could help breast cancer sufferers live up to twice as long without the disease progressing, according ...

A powerful, three-drug therapy for aggressive advanced breast cancer doubles the length of time before the cancer progresses, ...

A “huge breakthrough ” in new drug therapy for aggressive advanced breast cancer could potentially double the amount of time ...

A combination of two drugs that can block the growth of cancer cells has shown promising results in women with a form of ...

Jahani-Asl’s team found evidence that the drug — called edaravone — shows promise in suppressing the self-renewing cancerous ...

Innovative application of an existing drug offers promising alternative treatment to traditional chemotherapy for patients with appendix cancer.

Research has found a new combination of drugs could help women with breast cancer live nearly twice as long without the disease progressing, in a "potentially transformative" breakthrough ...

Elranatamab, an injection that treats myeloma, has been recommended for NHS use by the National Institute for Health and Care Excellence.

Multiple myeloma is a difficult to treat, rare and devastating form of cancer which can be debilitating, painful and has substantial impact on quality of life. There are limited treatment options so I ...

ALPMF's expanding lineup of cancer drugs, including zolbetuximab, positions them for substantial market growth and potential ...